EZR and neoplasm: In addition, ezrin inhibition could dramatically decreased lung metastases, including decreased the incidence (Fig. 7A-C), lower percentage of micro-metastatic cells in lung tissues (Fig. 7D), as well as less circulating tumor cells (CTCs) in blood (Fig. 7E) compared with vehicle.